Chemoinformaics analysis of Gelseoxazolidinine
| Molecular Weight | 428.485 | nRot | 3 |
| Heavy Atom Molecular Weight | 400.261 | nRig | 29 |
| Exact Molecular Weight | 428.195 | nRing | 7 |
| Solubility: LogS | -4.55 | nHRing | 5 |
| Solubility: LogP | 2.298 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 64.0922 |
| nHD | 0 | BPOL | 39.0498 |
| QED | 0.677 |
| Synth | 6.635 |
| Natural Product Likeliness | 1.854 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0.004 |
| HIA | 0.014 |
| CACO-2 | -5.104 |
| MDCK | 0.0000482 |
| BBB | 0.641 |
| PPB | 0.15327 |
| VDSS | 1.031 |
| FU | 0.746517 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.361 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.943 |
| CYP2c9-inh | 0.033 |
| CYP2c9-sub | 0.058 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.526 |
| CYP3a4-sub | 0.931 |
| CL | 5.105 |
| T12 | 0.051 |
| hERG | 0.041 |
| Ames | 0.84 |
| ROA | 0.734 |
| SkinSen | 0.045 |
| Carcinogencity | 0.819 |
| EI | 0.008 |
| Respiratory | 0.324 |
| NR-Aromatase | 0.883 |
| Antiviral | Yes |
| Prediction | 0.792176 |